中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

阿托伐他汀治疗急性缺血性脑卒中的临床效果

韩丰立1 ,辛涛2 ,杨菲3

(1.陕西省第四人民医院神经内科,陕西 西安,710000;2.第四军医大学唐都医院呼吸科,陕西 西安,710038; 3.苏州大学医学院,江苏 苏州,215123)

浏览次数:91次 下载次数:350次

摘要:

目的 探讨阿托伐他汀治疗急性缺血性脑卒中的临床疗效和安全性。方法 选取我院收治的80例急性缺血性脑卒中患者为研究对象,随机分为试验组和对照组,各40例。两组患者均给予常规治疗,对照组患者在常规治疗基础上给予口服肠溶 阿斯匹林片治疗。试验组患者在对照组基础上,给予口服阿托伐他汀治疗。比较两组患者的临床疗效、治疗前、后血脂水平及不良反应发生情况。结果 试验组患者的总有效率为90.00%,显著高于对照组的62.50%(P<0.05)。治疗后,试验组患者的 TG、TC、HDL-C 和LDL-C水平明显优于治疗前和对照组(P<0.05)。试验组患者不良反应总发生率为5.00%,显著低于对照 组的20.00%(P<0.05)。结论 阿托伐他汀治疗急性缺血性脑卒中临床效果显著,且不良反应轻微,值得临床推广应用。

关键词:缺血性脑卒中;阿托伐他汀;阿司匹林

中图分类号:R743.3文献标志码:A文章编号:2096-1413(2017)28-0029-02

    Clinical effect of atorvastatin in the treatment of acute ischemic stroke
    HAN Feng-li 1, XIN Tao 2, YANG Fei 3
    (1. Department of Neurology, the Fourth People``s Hospital of Shaanxi, Xi``an 710000; 2. Department of Respiration, Tangdu Hospital, the Fourth Military Medical University, Xi``an 710038; 3. Medical College of Soochow University, Suzhou 215123, China)

    ABSTRACT: Objective To assess the efficacy and safety of atorvastatin for treating acute ischemic stroke. Methods A total of 80 acute ischemic stroke patients admitted in our hospital were selected randomly divided into the experimental group and control group, with 40 cases in each group. All the patients received routine treatment, the patients in the control group were given aspirin tablet on the basis of routine treatment, and the intervention group was treated with atorvastatin based on the control group. The clinical effect, blood lipid levels and adverse reactions were compared between the two groups. Results The total effective rate of the experiment group was 90.00%, which was much higher than 62.50% of the control group (P<0.05). After treatment, the levels of TG, TC, HDL -C and LDL -C in the experimental group were better than those before treatment and those in the control group (P<0.05). The total incidence rate of adverse reactions of the experimental group was 5.00%, which was lower than 20.00% of the control group (P<0.05). Conclusion Atorvastatin has significant efficacy for treating acute ischemic stroke and has few adverse reactions, which deserves to be applied in clinic.
    KEYWORDS: ischemic stroke; atorvastatin; aspirin

    参考文献:
    [1] 张素玲.阿托伐他汀联合阿司匹林对急性缺血性脑卒中患者血脂及神经功能缺损程度的影响[J].河南医学研究,2016,25(9):1626-1627.
    [2] 张新安.阿托伐他汀钙治疗急性脑梗死的临床效果观察[J].临床合理用药杂志,2016,9(30):62-63.
    [3] 赵华,龚道恺.阿司匹林片联合阿托伐他汀钙片治疗急性脑梗死的临床研究[J].中国临床药理学杂志,2016,32(21):1934-1936,1941.
    [4] 周红霞,王兴元,范利娟,等.阿托伐他汀在急性缺血性脑卒中患者中的临床研究[J].中国临床药理学杂志,2016,32(1):72-74.
    [5] 于金梅.阿托伐他汀对缺血性脑卒中患者脑血管储备能力的影响分析[J].当代医学,2016,22(8):146-147.
    [6] 吴波,程晓明,聂水波,等.阿托伐他汀在缺血性脑卒中二级预防中的应用[J].中国实用神经疾病杂志,2016,19(13):120-121.

上一篇果酸联合盐酸米诺环素治疗中重度痤疮的疗效观察

下一篇胺碘酮对老年心律失常患者的作用以及安全性